231
Views
6
CrossRef citations to date
0
Altmetric
PAPERS

How Venture Capital Shapes Emerging Bio-clusters—A Cross-country Comparison

, &
Pages 441-463 | Received 01 Sep 2007, Accepted 01 Jan 2008, Published online: 11 Mar 2008

References

  • Audretsch , D. B. 2001 . The role of small firms in U.S. biotechnology clusters . Small Business Economics , 17 ( 1–2 ) : 3 – 15 .
  • Avnimelech , G. and Teubal , M. 2006 . Creating venture capital industries that co-evolve with high tech: Insights from an extended industry life cycle perspective of the Israeli experience . Research Policy , 35 ( 10 ) : 1477 – 1498 .
  • Backlund , A. , Häggblad , H. , Markusson , N. , Norgren , L. and Sandström , A. 2001 . The Swedish Biotechnology Innovation System , Stockholm : Vinnova .
  • Baum , J. A. C. and Silverman , B. S. 2004 . Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups . Journal of Business Venturing , 19 ( 3 ) : 411 – 436 .
  • Bisgaard , T. and Rosted , J. 2004 . Et benchmark studie af venturemarkedet—hvad kan Danmark lære? , Copenhagen : FORA .
  • Brink , J. , McKelvey , M. and Smith , K. 2004 . “ Conceptualising and measuring modern biotechnology ” . In The Economic Dynamics of Modern Biotechnologies , Edited by: Laage-Hellman , J. , McKelvey , M. and Rickne , A. 20 – 40 . Cheltenham : Edward Elgar Publishing .
  • Champenois , C. , Engel , D. and Oliver , H. 2006 . What kind of German biotechnology start-ups do venture capital companies and corporate investors prefer for equity investments? . Applied Economics , 38 ( 5 ) : 505 – 518 .
  • Cooke , P. 2002 . Biotechnology clusters as regional, sectoral innovation systems . International Regional Science Review , 25 ( 1 ) : 8 – 37 .
  • Cooke , P. 2006 . Global bioregions: Knowledge domains, capabilities and innovation system networks . Industry and Innovation , 13 ( 4 ) : 437 – 458 .
  • Cooke , P. 2007 . European asymmetries: A comparative analysis of German and UK biotechnology clusters . Science and Public Policy , 37 ( 7 ) : 454 – 474 .
  • Dahlgren , H. and Valentin , F. 2007 . Shaken not Stirred—Multinational Takeovers in Sweden's Pharmaceutical Industry , Copenhagen : Research Centre on Biotech Business, Copenhagen Business School . Biotech Business Working Paper 2007-04
  • Deeds , D. L. , Decarolis , D. M. and Coombs , J. E. 1997 . The impact of firm specific capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry . Journal of Business Venturing , 12 : 31 – 46 .
  • Deng , Z. , Lev , B. and Narin , F. 1999 . Science and technology as predictors of stock performance . Financial Analysts Journal , 55 ( 3 ) : 20 – 32 .
  • Ernst and Young . 2006 . Beyond Borders: The Global Biotechnology Report 2006 , Copenhagen : Ernst & Young .
  • Feldman , M. P. and Francis , J. L. 2003 . Fortune favours the prepared region: The case of entrepreneurship and the capitol region biotechnology cluster . European Planning Studies , 11 ( 7 ) : 765 – 788 .
  • Feldman , M. P. , Valentin , F. and Yoon , J. W. Organizational Legacy and Firm Performance . Paper presented at the DRUID Summer Conference . June , Copenhagen . CBS .
  • Florida , R. L. and Kenney , M. 1988 . Venture capital-financed innovation and technological change in the USA . Research Policy , 17 : 119 – 137 .
  • Fried , V. H. and Hisrich , R. D. 1995 . The venture capitalist: A relationship investor . California Management Review , 37 ( 2 ) : 101 – 114 .
  • Guedj , I. and Scharfstein , D. 2004 . Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms , Cambridge , MA : National Bureau of Economic Research . NBER Working Paper 10933
  • Hand , J. R. M. 2005 . The value relevance of financial statements in the venture capital market . The Accounting Review , 80 ( 2 ) : 613 – 648 .
  • Hausman , J. A. 1978 . Specification Tests in Econometrics . Econometrica , 46 ( 6 ) : 1251 – 1271 .
  • Hellmann , T. and Puri , M. 2002 . Venture capital and the professionalization of start-up firms: Empirical evidence . Journal of Finance , 57 ( 1 ) : 169
  • Hsu , D. H. 2007 . Experienced entrepreneurial founders, organizational capital, and venture capital funding . Research Policy , 36 ( 5 ) : 722 – 741 .
  • Isaksson , A. 1999 . Effekter av venture capital i Sverige , Stockholm : NUTEK .
  • Lerner , J. , Shane , H. and Tsai , A. 2003 . Do equity financing cycles matter? Evidence from biotechnology alliances . Journal of Financial Economics , 67 ( 3 ) : 411 – 446 .
  • Luukkonen , T. and Mari , M. 2007 . ‘Coaching’ small biotech companies into success . International Journal of Biotechnology , 9 ( 6 ) : 548 – 568 .
  • Lynskey , M. J. 2006 . Editorial: A strategy to optimise the business value of intellectual property . International Journal of Biotechnology , 8 ( 3–4 ) : 146 – 168 .
  • McKelvey , M. and Orsenigo , L. 2006 . “ Introduction ” . In The Economics of Biotechnology , Edited by: McKelvey , M. and Orsenigo , L. Cheltenham : Edward Elgar Publishing .
  • McMillan , G. S. , Narin , F. and Deeds , D. L. 2000 . An analysis of the critical role of public science in innovation: The case of biotechnology . Research Policy , 29 ( 1 ) : 1 – 8 .
  • Moran , N. 2006 . Danish biotech outperforms its European counterparts . Nature Biotechnology , 24 ( 12 ) : 1460 – 1461 .
  • Muller , C. and Fujiwara , T. 2003 . The entrepreneurial environment for biotech start-ups in Germany and Japan . International Journal of Biotechnology , 5 ( 1 ) : 76 – 94 .
  • Nicholson , S. , Danzon , P. M. and McCullough , J. 2005 . Biotech–pharmaceutical alliances as a signal of asset and firm quality . The Journal of Business , 78 ( 4 ) : 1433 – 1464 .
  • Nilsson , A. 2000 . Biotechnology firms in Sweden . Small Business Economics , 17 ( 1 ) : 93 – 103 .
  • Organization for Economic Cooperation and Development (OECD) . 2005 . A Framework for Biotechnology Statistics , Paris : OECD .
  • Organization for Economic Cooperation and Development (OECD) . 2007 . OECD Small and Medium Enterprise Companies Outlook , Paris : OECD .
  • Owen-Smith , J. , Riccaboni , M. , Pammolli , F. and Powell , W. W. 2002 . A comparison of U.S. and European university–industry relations in the life sciences . Management Science , 48 ( 1 ) : 24 – 43 .
  • Powell , W. W. , Koput , K. W. and Bowie , J. I. 2002 . The spatial clustering of science and capital: Accounting for biotech firm–venture capital relationships . Regional Studies , 36 ( 3 ) : 291 – 305 .
  • Stuart , T. E. , Ozdemir , S. Z. and Ding , W. W. 2007 . Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains . Research Policy , 36 ( 4 ) : 477 – 498 .
  • Tomas , G. B. and Jorge , N. 2007 . The issue of asymmetrical growth in specialised biotechnology firms in the USA and the UK . International Journal of Biotechnology , 9 ( 1 ) : 87 – 100 .
  • Valentin , F. and Dahlgren , H. 2007 . Alliances of Scandinavian Biotech Start-ups and their Effects on Financial Performance , Copenhagen : Research Centre on Biotech Business, Copenhagen Business School . Biotech Business Working Paper 2007-01
  • Valentin , F. and Jensen , R. L. 2007 . The Imprint of Founders on Biotech Firms , Copenhagen : Research Centre on Biotech Business, Copenhagen Business School . Biotech Business Working Paper 2007-02
  • Valentin , F. , Dahlgren , H. and Jensen , R. L. 2006 . Structure, Employment and Performance in Biotech Firms—Comparison of Danish and Swedish Drug Discovery Firms , Copenhagen : Research Centre on Biotech Business, Copenhagen Business School . Biotech Business Working Paper 2006-06
  • Valentin , F. , Jensen , R. L. and Dahlgren , H. 2007 . Research strategies in science-based start-ups. Effects on performance in Danish and Swedish biotechnology . Technology Analysis & Strategic Management , 19 ( 3 ) : 303 – 328 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.